SG11201600221YA - Elucidation of ion exchange chromatography input optimization - Google Patents
Elucidation of ion exchange chromatography input optimizationInfo
- Publication number
- SG11201600221YA SG11201600221YA SG11201600221YA SG11201600221YA SG11201600221YA SG 11201600221Y A SG11201600221Y A SG 11201600221YA SG 11201600221Y A SG11201600221Y A SG 11201600221YA SG 11201600221Y A SG11201600221Y A SG 11201600221YA SG 11201600221Y A SG11201600221Y A SG 11201600221YA
- Authority
- SG
- Singapore
- Prior art keywords
- elucidation
- ion exchange
- exchange chromatography
- input optimization
- chromatography input
- Prior art date
Links
- 238000004255 ion exchange chromatography Methods 0.000 title 1
- 238000005457 optimization Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8658—Optimising operation parameters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3847—Multimodal interactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845890P | 2013-07-12 | 2013-07-12 | |
| PCT/US2014/046338 WO2015006686A1 (en) | 2013-07-12 | 2014-07-11 | Elucidation of ion exchange chromatography input optimization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600221YA true SG11201600221YA (en) | 2016-02-26 |
Family
ID=51257626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600221YA SG11201600221YA (en) | 2013-07-12 | 2014-07-11 | Elucidation of ion exchange chromatography input optimization |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10274466B2 (en) |
| EP (2) | EP3019516B1 (en) |
| JP (2) | JP6462681B2 (en) |
| KR (1) | KR102251127B1 (en) |
| CN (1) | CN105377873B (en) |
| AU (1) | AU2014287044B2 (en) |
| BR (1) | BR112016000231A8 (en) |
| CA (1) | CA2918052A1 (en) |
| ES (1) | ES2705700T3 (en) |
| HR (1) | HRP20190071T1 (en) |
| IL (1) | IL243305B (en) |
| MX (1) | MX368107B (en) |
| PL (1) | PL3019516T3 (en) |
| RU (1) | RU2016104542A (en) |
| SG (1) | SG11201600221YA (en) |
| SI (1) | SI3019516T1 (en) |
| TR (1) | TR201818966T4 (en) |
| WO (1) | WO2015006686A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105377873B (en) | 2013-07-12 | 2021-03-30 | 豪夫迈·罗氏有限公司 | Elucidation of ion exchange chromatography input optimization |
| US11460455B2 (en) | 2014-11-12 | 2022-10-04 | Cytiva Sweden Ab | Method and system for determining the influence of experimental parameters on a liquid chromatography protocol |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
| KR20200139720A (en) * | 2018-04-02 | 2020-12-14 | 암젠 인크 | Erenumab composition and use thereof |
| EP3817756A4 (en) * | 2018-07-05 | 2022-03-30 | Ovation Diagnostics LLC | ANTI-BCL-2 ANTIBODIES AND IMMUNOLOGICAL ASSAY FOR THE DIAGNOSIS OF CANCER |
| KR20200080748A (en) * | 2018-12-27 | 2020-07-07 | 주식회사 폴루스 | A Method for Purifying Proinsulin Using Anion Exchange Chromatography |
| WO2024261724A1 (en) * | 2023-06-23 | 2024-12-26 | Lupin Limited | Ion-exchange chromatography for separation and analysis of charge variants |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (en) | 1978-01-06 | 1979-08-03 | David Bernard | DRYER FOR SCREEN-PRINTED SHEETS |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4666855A (en) * | 1985-07-31 | 1987-05-19 | Massachusetts Institute Of Technology | Rapid method for determining the isoelectric point for amphoteric molecules |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| ES2037273T3 (en) | 1987-04-11 | 1993-06-16 | Ciba-Geigy Ag | ISOELECTRIC TARGETING PROCESS AND MEANS TO CARRY OUT SUCH PROCESS. |
| CA1338518C (en) | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Antibody heteroconjugates for the killing of hiv-infected cells |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
| ES2096590T3 (en) | 1989-06-29 | 1997-03-16 | Medarex Inc | BI-SPECIFIC REAGENTS FOR AIDS THERAPY. |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| ATE204902T1 (en) | 1990-06-29 | 2001-09-15 | Large Scale Biology Corp | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| CA2102511A1 (en) | 1991-05-14 | 1992-11-15 | Paul J. Higgins | Heteroconjugate antibodies for treatment of hiv infection |
| JP4124480B2 (en) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | Immunoglobulin variants |
| IE922437A1 (en) | 1991-07-25 | 1993-01-27 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
| FI941572L (en) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Combination and method of use of anti-erbB-2 monoclonal antibodies |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| WO1993011161A1 (en) | 1991-11-25 | 1993-06-10 | Enzon, Inc. | Multivalent antigen-binding proteins |
| ATE503496T1 (en) | 1992-02-06 | 2011-04-15 | Novartis Vaccines & Diagnostic | BIOSYNTHETIC BINDING PROTEIN FOR TUMOR MARKERS |
| CA2128862C (en) | 1992-02-11 | 2008-05-20 | Jonathan G. Seidman | Homogenotization of gene-targeting events |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| JPH08500017A (en) | 1992-08-17 | 1996-01-09 | ジェネンテク，インコーポレイテッド | Bispecific immune adhesin |
| ATE139900T1 (en) | 1992-11-13 | 1996-07-15 | Idec Pharma Corp | THERAPEUTIC USE OF CHIMERIC AND LABELED ANTIBODIES AGAINST HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR THE TREATMENT OF B CELL LYMPHOMA |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| ES2292682T3 (en) | 1998-05-06 | 2008-03-16 | Genentech, Inc. | PURIFICATION OF ANTIBODIES THROUGH IONIC EXCHANGE CHROMATOGRAPHY. |
| SE9803838D0 (en) | 1998-11-09 | 1998-11-09 | Knut Irgum | A chromatography method and a column material useful in said method |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US6451987B1 (en) | 1999-03-15 | 2002-09-17 | Novo Nordisk A/S | Ion exchange chromatography of proteins and peptides |
| AU4216700A (en) * | 1999-04-05 | 2000-10-23 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
| US8372954B2 (en) | 2000-12-22 | 2013-02-12 | National Research Council Of Canada | Phage display libraries of human VH fragments |
| JP2005289809A (en) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | Mutant heavy chain antibody |
| CA2496060C (en) | 2002-09-11 | 2015-08-04 | Genentech, Inc. | Protein purification by ion exchange chromatography |
| JP2007500852A (en) * | 2003-05-16 | 2007-01-18 | クリオバイオフィジカ， インコーポレイテッド | External gradient chromatofocusing |
| AU2004220325B2 (en) | 2003-06-30 | 2011-05-12 | Domantis Limited | Polypeptides |
| US7906630B2 (en) | 2004-04-27 | 2011-03-15 | PerkinElmer Heath Sciences, Inc. | Method for identifying peptides in a biological sample |
| GB2430794B (en) * | 2004-05-20 | 2009-10-21 | Waters Investments Ltd | Method and apparatus for identifying proteins in mixtures |
| WO2006007429A1 (en) | 2004-06-16 | 2006-01-19 | Ciphergen Biosystems, Inc. | Multichemistry fractionation |
| JP2008510466A (en) | 2004-08-19 | 2008-04-10 | ジェネンテック・インコーポレーテッド | Polypeptide variants with altered effector function |
| KR20070072510A (en) | 2004-08-30 | 2007-07-04 | 론자 바이올로직스 피엘씨 | Affinity- and Ion-Exchange Chromatography for Antibody Purification |
| NZ553500A (en) | 2004-09-23 | 2009-11-27 | Genentech Inc Genentech Inc | Cysteine engineered antibodies and conjugates withCysteine engineered antibodies and conjugates with a free cysteine amino acid in the heavy chain a free cysteine amino acid in the heavy chain |
| JP2006087394A (en) * | 2004-09-27 | 2006-04-06 | Wako Pure Chem Ind Ltd | Method for extracting nucleic acid and kit for extracting nucleic acid |
| GB0613753D0 (en) * | 2006-07-11 | 2006-08-23 | Norwegian Radium Hospital Res | Method |
| JP2010089001A (en) | 2008-10-07 | 2010-04-22 | Japan Organo Co Ltd | Chromatograph separation method |
| SG174258A1 (en) | 2009-03-06 | 2011-10-28 | Genentech Inc | Antibody formulation |
| CN102471377B (en) * | 2009-07-24 | 2015-04-22 | 霍夫曼-拉罗奇有限公司 | Optimizing the production of antibodies |
| RU2571929C2 (en) * | 2009-09-01 | 2015-12-27 | Дженентек, Инк. | Improved protein purification by means of modified eluating of protein a |
| JP2013530406A (en) | 2010-07-09 | 2013-07-25 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | Chromatographic method and medium used therefor |
| WO2012102104A1 (en) * | 2011-01-24 | 2012-08-02 | シャープ株式会社 | Exposure apparatus, liquid crystal display device and method for manufacturing same |
| AU2012234689A1 (en) * | 2011-03-31 | 2013-10-17 | Apotex Technologies Inc. | Prodrugs of D-gamma-glutamyl-D-tryptophan and D-gamma- glutamyl-L-tryptophan |
| CN105051528A (en) | 2012-11-15 | 2015-11-11 | 弗·哈夫曼-拉罗切有限公司 | Ionic Strength-Mediated pH Gradient Ion Exchange Chromatography |
| CN105377873B (en) | 2013-07-12 | 2021-03-30 | 豪夫迈·罗氏有限公司 | Elucidation of ion exchange chromatography input optimization |
-
2014
- 2014-07-11 CN CN201480039460.3A patent/CN105377873B/en active Active
- 2014-07-11 BR BR112016000231A patent/BR112016000231A8/en active Search and Examination
- 2014-07-11 SG SG11201600221YA patent/SG11201600221YA/en unknown
- 2014-07-11 MX MX2016000181A patent/MX368107B/en active IP Right Grant
- 2014-07-11 HR HRP20190071TT patent/HRP20190071T1/en unknown
- 2014-07-11 KR KR1020167003178A patent/KR102251127B1/en active Active
- 2014-07-11 EP EP14745049.8A patent/EP3019516B1/en active Active
- 2014-07-11 RU RU2016104542A patent/RU2016104542A/en not_active Application Discontinuation
- 2014-07-11 AU AU2014287044A patent/AU2014287044B2/en not_active Ceased
- 2014-07-11 SI SI201431039T patent/SI3019516T1/en unknown
- 2014-07-11 WO PCT/US2014/046338 patent/WO2015006686A1/en not_active Ceased
- 2014-07-11 ES ES14745049T patent/ES2705700T3/en active Active
- 2014-07-11 EP EP18204792.8A patent/EP3536699A1/en not_active Withdrawn
- 2014-07-11 JP JP2016525805A patent/JP6462681B2/en active Active
- 2014-07-11 US US14/904,422 patent/US10274466B2/en active Active
- 2014-07-11 TR TR2018/18966T patent/TR201818966T4/en unknown
- 2014-07-11 CA CA2918052A patent/CA2918052A1/en not_active Abandoned
- 2014-07-11 PL PL14745049T patent/PL3019516T3/en unknown
-
2015
- 2015-12-23 IL IL243305A patent/IL243305B/en active IP Right Grant
-
2018
- 2018-12-26 JP JP2018242206A patent/JP2019090818A/en active Pending
-
2019
- 2019-03-12 US US16/351,372 patent/US10921297B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016104542A (en) | 2017-08-17 |
| MX368107B (en) | 2019-09-18 |
| US10274466B2 (en) | 2019-04-30 |
| SI3019516T1 (en) | 2019-02-28 |
| HK1222183A1 (en) | 2017-06-23 |
| ES2705700T3 (en) | 2019-03-26 |
| EP3019516B1 (en) | 2018-11-14 |
| US20160161455A1 (en) | 2016-06-09 |
| BR112016000231A8 (en) | 2019-12-31 |
| WO2015006686A1 (en) | 2015-01-15 |
| KR102251127B1 (en) | 2021-05-11 |
| PL3019516T3 (en) | 2019-04-30 |
| CN105377873B (en) | 2021-03-30 |
| JP6462681B2 (en) | 2019-01-30 |
| KR20160030251A (en) | 2016-03-16 |
| HRP20190071T1 (en) | 2019-02-22 |
| TR201818966T4 (en) | 2019-01-21 |
| IL243305B (en) | 2019-09-26 |
| JP2016529489A (en) | 2016-09-23 |
| EP3019516A1 (en) | 2016-05-18 |
| AU2014287044A1 (en) | 2016-02-11 |
| EP3536699A1 (en) | 2019-09-11 |
| CA2918052A1 (en) | 2015-01-15 |
| JP2019090818A (en) | 2019-06-13 |
| US20190310234A1 (en) | 2019-10-10 |
| US10921297B2 (en) | 2021-02-16 |
| WO2015006686A8 (en) | 2018-10-04 |
| CN105377873A (en) | 2016-03-02 |
| MX2016000181A (en) | 2016-03-09 |
| AU2014287044B2 (en) | 2020-02-06 |
| IL243305A0 (en) | 2016-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244320B (en) | Methods for application specific access control | |
| EP2983804A4 (en) | Ion exchange purification of mrna | |
| GB2540483B (en) | Improved lenses | |
| EP2901307A4 (en) | Basketball shot-tracking system | |
| GB201301764D0 (en) | Actuation of fluid-filled lenses | |
| GB2522503B (en) | Ion modification | |
| GB201317467D0 (en) | Magnetic glasses | |
| PL3011415T3 (en) | Electronic-scribed input | |
| IL243305A0 (en) | Elucidation of ion exchange chromatography input optimization | |
| IL243414A0 (en) | Affinity chromatography matrix | |
| DK3050055T3 (en) | REPLACING MULTI-CHANNEL AUDIO USING INTERPOLATED MATRIX | |
| GB2530454B (en) | Optimization of instruction groups across group boundaries | |
| EP3015449A4 (en) | (meth)acrylate production system | |
| EP2969754A4 (en) | Design optimizer system | |
| GB2517670B (en) | Ion modification | |
| GB2508683B (en) | Program execution optimization for multi-stage manycore processors | |
| GB201301859D0 (en) | Regeneration of an ion exchange column | |
| EP3095483A4 (en) | Radiotherapy spacer | |
| GB2509808B (en) | Improved lenses | |
| GB2522739B (en) | Charge-stripping of multiply-charged ions | |
| TWM475581U (en) | Analysis system of behavior | |
| FI20135404L (en) | Process optimization | |
| GB2518518B (en) | Spacer | |
| AU4911P (en) | LMV200 Lomandra hystrix | |
| GB201319952D0 (en) | Methods of isolating ions |